• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耐药性:从分子机制到潜在疗法(综述)

Drug‑resistant : From molecular mechanisms to potential therapeutics (Review).

作者信息

Wu Hao-Jia, Xiao Zhi-Gang, Lv Xiao-Juan, Huang Hai-Tang, Liao Chu, Hui Chen-Yang, Xu Yue, Li Heng-Fei

机构信息

Clinical College of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, Hubei 430065, P.R. China.

Department of Orthopedics, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, Hubei 430061, P.R. China.

出版信息

Exp Ther Med. 2023 Mar 23;25(5):209. doi: 10.3892/etm.2023.11908. eCollection 2023 May.

DOI:10.3892/etm.2023.11908
PMID:37090073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10119666/
Abstract

Bacterial drug resistance is increasingly becoming an important problem that needs to be solved urgently in modern clinical practices. Infection caused by is a serious threat to the life and health of patients. The drug resistance rate of strains is increasing, thus research on the drug resistance of has also seen an increase. When patients are infected with drug-resistant , the availability of suitable antibiotics commonly used in clinical practices is becoming increasingly limited and the prognosis of patients is worsening. Studying the molecular mechanism of the drug resistance of is fundamental to solving the problem of drug-resistant and potentially other 'super bacteria'. Drug resistance mechanisms primarily include enzymes, membrane proteins, efflux pumps and beneficial mutations. Research on the underlying mechanisms provides a theoretical basis for the use and development of antibiotics and the development of novel treatment methods.

摘要

细菌耐药性日益成为现代临床实践中亟待解决的重要问题。由[未提及具体细菌名称]引起的感染对患者的生命健康构成严重威胁。[未提及具体细菌名称]菌株的耐药率不断上升,因此对[未提及具体细菌名称]耐药性的研究也日益增多。当患者感染耐药性[未提及具体细菌名称]时,临床常用的合适抗生素的可用性越来越有限,患者的预后也在恶化。研究[未提及具体细菌名称]的耐药分子机制是解决耐药性[未提及具体细菌名称]以及潜在的其他“超级细菌”问题的基础。耐药机制主要包括酶、膜蛋白、外排泵和有益突变。对潜在机制的研究为抗生素的使用和开发以及新治疗方法的开发提供了理论依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3b/10119666/8964d8e9c1d8/etm-25-05-11908-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3b/10119666/8964d8e9c1d8/etm-25-05-11908-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3b/10119666/8964d8e9c1d8/etm-25-05-11908-g00.jpg

相似文献

1
Drug‑resistant : From molecular mechanisms to potential therapeutics (Review).耐药性:从分子机制到潜在疗法(综述)
Exp Ther Med. 2023 Mar 23;25(5):209. doi: 10.3892/etm.2023.11908. eCollection 2023 May.
2
An Analysis of the Novel Fluorocycline TP-6076 Bound to Both the Ribosome and Multidrug Efflux Pump AdeJ from Acinetobacter baumannii.分析氟环素 TP-6076 与鲍曼不动杆菌核糖体和多药外排泵 AdeJ 的结合。
mBio. 2021 Feb 22;13(1):e0373221. doi: 10.1128/mbio.03732-21. Epub 2022 Feb 1.
3
Multidrug resistant Acinetobacter baumannii--the role of AdeABC (RND family) efflux pump in resistance to antibiotics.多重耐药鲍曼不动杆菌——AdeABC(耐药结节化细胞分化家族)外排泵在抗生素耐药中的作用
Folia Histochem Cytobiol. 2008;46(3):257-67. doi: 10.2478/v10042-008-0056-x.
4
Cryo-EM Determination of Eravacycline-Bound Structures of the Ribosome and the Multidrug Efflux Pump AdeJ of Acinetobacter baumannii.冷冻电镜测定埃拉霉素结合的鲍曼不动杆菌核糖体和多药外排泵 AdeJ 的结构。
mBio. 2021 Jun 29;12(3):e0103121. doi: 10.1128/mBio.01031-21. Epub 2021 May 28.
5
Copper Resistance of the Emerging Pathogen Acinetobacter baumannii.新兴病原体鲍曼不动杆菌的铜抗性
Appl Environ Microbiol. 2016 Sep 30;82(20):6174-6188. doi: 10.1128/AEM.01813-16. Print 2016 Oct 15.
6
Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumannii.替加环素异质性耐药和鲍曼不动杆菌临床分离株的耐药机制。
Microbiol Spectr. 2021 Oct 31;9(2):e0101021. doi: 10.1128/Spectrum.01010-21. Epub 2021 Sep 15.
7
Developing new therapeutic approaches for treating infections caused by multi-drug resistant Acinetobacter baumannii: Acinetobacter baumannii therapeutics.开发治疗多重耐药鲍曼不动杆菌引起感染的新治疗方法:鲍曼不动杆菌治疗学。
J Infect. 2020 Dec;81(6):857-861. doi: 10.1016/j.jinf.2020.10.016. Epub 2020 Oct 25.
8
Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates.解析广泛耐药鲍曼不动杆菌临床分离株中多粘菌素耐药机制。
mBio. 2019 Jul 16;10(4):e01083-19. doi: 10.1128/mBio.01083-19.
9
A novel decoy strategy for polymyxin resistance in .一种用于对抗多粘菌素耐药性的新型诱饵策略。
Elife. 2021 Jun 28;10:e66988. doi: 10.7554/eLife.66988.
10
CRISPR-Cas in Acinetobacter baumannii Contributes to Antibiotic Susceptibility by Targeting Endogenous .鲍曼不动杆菌中的 CRISPR-Cas 通过靶向内源性 . 有助于抗生素敏感性。
Microbiol Spectr. 2022 Aug 31;10(4):e0082922. doi: 10.1128/spectrum.00829-22. Epub 2022 Aug 8.

引用本文的文献

1
Exploration of Phosphoproteins in .……中磷蛋白的探索
Pathogens. 2025 Jul 24;14(8):732. doi: 10.3390/pathogens14080732.
2
High Prevalence of Virulence and Genes Encoding Carbapenemases Among Isolates from Hospitalised Patients in Three Regions of Poland.波兰三个地区住院患者分离株中耐药性及碳青霉烯酶编码基因的高流行率
Pathogens. 2025 Jul 24;14(8):731. doi: 10.3390/pathogens14080731.
3
Isolation and characterization of phages ΦZC2 and ΦZC3 against carbapenem-resistant Acinetobacter baumannii, and efficacy of ΦZC3 on A549 cells.

本文引用的文献

1
Combination of BauA and OmpA elicit immunoprotection against Acinetobacter baumannii in a murine sepsis model.BauA 和 OmpA 的联合使用可在小鼠脓毒症模型中引发针对鲍曼不动杆菌的免疫保护。
Microb Pathog. 2022 Dec;173(Pt A):105874. doi: 10.1016/j.micpath.2022.105874. Epub 2022 Nov 8.
2
Herbal Products and Their Active Constituents Used Alone and in Combination with Antibiotics against Multidrug-Resistant Bacteria.草药产品及其活性成分单独使用和与抗生素联合使用对抗多药耐药菌。
Planta Med. 2023 Feb;89(2):168-182. doi: 10.1055/a-1890-5559. Epub 2022 Aug 22.
3
Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility.
抗碳青霉烯类耐药鲍曼不动杆菌噬菌体ΦZC2和ΦZC3的分离、鉴定及其对A549细胞的作用
Virol J. 2025 Jul 30;22(1):262. doi: 10.1186/s12985-025-02885-6.
4
treatment strategies: a review of therapeutic challenges and considerations.治疗策略:治疗挑战与考量综述
Antimicrob Agents Chemother. 2025 Aug 6;69(8):e0106324. doi: 10.1128/aac.01063-24. Epub 2025 Jul 9.
5
Phenotypical and Molecular Characterization of Isolated from Hospitalized Patients During the COVID-19 Pandemic in Brazil.巴西新冠疫情期间从住院患者中分离出的[具体内容缺失]的表型和分子特征。
Life (Basel). 2025 Apr 8;15(4):623. doi: 10.3390/life15040623.
6
Clinical burden of Acinetobacter baumannii, including carbapenem-resistant A. baumannii, in hospitalized adult patients in the USA between 2018 and 2022.2018年至2022年间美国住院成年患者中鲍曼不动杆菌(包括耐碳青霉烯鲍曼不动杆菌)的临床负担。
BMC Infect Dis. 2025 Apr 17;25(1):549. doi: 10.1186/s12879-025-10749-1.
7
Comprehensive molecular epidemiology of Acinetobacter baumannii from diverse sources in Nigeria.尼日利亚不同来源鲍曼不动杆菌的综合分子流行病学研究
BMC Microbiol. 2025 Mar 31;25(1):178. doi: 10.1186/s12866-025-03917-5.
8
Mefloquine reduces the bacterial membrane fluidity of and distorts the bacterial membrane when combined with polymyxin B.甲氟喹与多粘菌素B联合使用时,可降低细菌膜流动性并使细菌膜变形。
mBio. 2025 Apr 9;16(4):e0401624. doi: 10.1128/mbio.04016-24. Epub 2025 Feb 25.
9
The Evolution of Antimicrobial Resistance in and New Strategies to Fight It.抗菌药物耐药性的演变及应对新策略
Antibiotics (Basel). 2025 Jan 14;14(1):85. doi: 10.3390/antibiotics14010085.
10
Unseen Enemy: Mechanisms of Multidrug Antimicrobial Resistance in Gram-Negative ESKAPE Pathogens.无形的敌人:革兰氏阴性ESKAPE病原体中的多重耐药抗菌机制
Antibiotics (Basel). 2025 Jan 9;14(1):63. doi: 10.3390/antibiotics14010063.
多黏菌素 E 联合或不联合美满霉素对不同米诺环素敏感性的碳青霉烯类药物耐药鲍曼不动杆菌的活性。
Microbiol Spectr. 2022 Jun 29;10(3):e0054222. doi: 10.1128/spectrum.00542-22. Epub 2022 Jun 1.
4
Activity of Peptide Antibiotics in Combination With Other Antimicrobials on Extensively Drug-Resistant in the Planktonic and Biofilm Cell.肽类抗生素与其他抗菌药物联合对浮游菌和生物膜细胞中广泛耐药菌的活性
Front Pharmacol. 2022 May 11;13:890955. doi: 10.3389/fphar.2022.890955. eCollection 2022.
5
Antimicrobial Photodynamic Therapy Mediated by Fotenticine and Methylene Blue on Planktonic Growth, Biofilms, and Burn Infections of .由福替辛和亚甲蓝介导的抗菌光动力疗法对浮游生长、生物膜及烧伤感染的作用
Antibiotics (Basel). 2022 May 4;11(5):619. doi: 10.3390/antibiotics11050619.
6
The role of quorum sensing, biofilm formation, and iron acquisition as key virulence mechanisms in Acinetobacter baumannii and the corresponding anti-virulence strategies.群体感应、生物膜形成和铁摄取作为鲍曼不动杆菌关键毒力机制的作用及相应的抗毒力策略。
Microbiol Res. 2022 Jul;260:127032. doi: 10.1016/j.micres.2022.127032. Epub 2022 Apr 12.
7
Convergence of Biofilm Formation and Antibiotic Resistance in Infection.感染中生物膜形成与抗生素耐药性的趋同
Front Med (Lausanne). 2022 Mar 24;9:793615. doi: 10.3389/fmed.2022.793615. eCollection 2022.
8
Carbapenem-resistant Acinetobacter baumannii: Colonization, Infection and Current Treatment Options.耐碳青霉烯鲍曼不动杆菌:定植、感染及当前的治疗选择
Infect Dis Ther. 2022 Apr;11(2):683-694. doi: 10.1007/s40121-022-00597-w. Epub 2022 Feb 17.
9
Therapeutic strategies against potential antibiofilm targets of multidrug-resistant Acinetobacter baumannii.针对多药耐药鲍曼不动杆菌潜在抗生物膜靶点的治疗策略。
J Cell Physiol. 2022 Apr;237(4):2045-2063. doi: 10.1002/jcp.30683. Epub 2022 Jan 26.
10
A naturally inspired antibiotic to target multidrug-resistant pathogens.一种受自然启发的抗生素,用于靶向抗多种药物的病原体。
Nature. 2022 Jan;601(7894):606-611. doi: 10.1038/s41586-021-04264-x. Epub 2022 Jan 5.